Q2 2026 13F · SEC CIK 921531
Globeflex Capital L P
Asset managerFiled 2026-08-12 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $782.6M
- Reported positions
- 394
- Top holdings a year, 3 yrs
- +17.5%
- Average holding period
- 1.8 yrs
Globeflex Capital L P is an asset manager that reported 394 positions worth $782.6M in its Q2 2026 13F, filed 2026-08-12. Its largest holdings were Intercorp Finl Svcs Inc (IFS, 3.0%), Blue Bird Corp (BLBD, 2.0%), Exelixis Inc (EXEL, 1.8%). A portfolio copying its top holdings returned 17.5% a year over the last 3 years, against 20.4% for the S&P 500.
Globeflex Capital L P holdings largest 50 of 394 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Globeflex Capital L P bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- ANIP Ani Pharmaceuticals Inc+29.0% shares
- DAVE Dave Inc+15.0% shares
- SNX TD SYNNEX Corp+13.7% shares
Reduced
- MKSI Mks Inc.-16.3% shares
- MEDP Medpace Hldgs Inc-15.1% shares
- FIX Comfort Sys USA Inc-13.1% shares
- ACLS Axcelis Technologies Inc-11.9% shares
- PAHC Phibro Animal Health Corp-9.9% shares
- RSI Rush Street Interactive Inc-9.5% shares
- KLIC Kulicke & Soffa Industries Inc-9.2% shares
- ESE Esco Technologies Inc-8.6% shares
Left the top 50
- CPRX Catalyst Pharmaceuticals Incwas 1.7%
- MRX Marex Group PLCwas 1.4%
- BAP Credicorp Ltdwas 1.4%
- NXT Nextpower Incwas 1.0%
- XP Xp Incwas 1.0%
- RIGL Rigel Pharmaceuticals Incwas 0.9%
- STRL Sterling Infrastructure Incwas 0.8%
- G Genpact Limitedwas 0.7%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +33.5% /yr
- S&P 500 +20.1%
- 3 years
- +17.5% /yr
- S&P 500 +20.4%
- 5 years
- +8.4% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $782.6M | 394 |
| Q1 2026 | $660.8M | 387 |
| Q4 2025 | $653.3M | 400 |
| Q3 2025 | $649.5M | 406 |
| Q2 2025 | $1.2B | 418 |
| Q1 2025 | $1.1B | 424 |
| Q4 2024 | $1.2B | 429 |
| Q3 2024 | $1.0B | 464 |
| Q2 2024 | $957.2M | 466 |
| Q1 2024 | $1.0B | 478 |
| Q4 2023 | $979.6M | 471 |
| Q3 2023 | $854.3M | 463 |
Questions about Globeflex Capital L P's portfolio
What stocks does Globeflex Capital L P own?
Globeflex Capital L P's latest 13F, for Q2 2026 and filed Aug 12, 2026, lists 394 positions worth $782.6M. The largest are Intercorp Finl Svcs Inc (IFS) at 3.0%, Blue Bird Corp (BLBD) at 2.0%, Exelixis Inc (EXEL) at 1.8%, Copa Holdings SA (CPA) at 1.7% and Ati Inc (ATI) at 1.7%.
What did Globeflex Capital L P buy last quarter?
In Q2 2026, Globeflex Capital L P added Ani Pharmaceuticals Inc (ANIP) (+29.0% shares), Dave Inc (DAVE) (+15.0% shares) and TD SYNNEX Corp (SNX) (+13.7% shares), compared with its Q1 2026 filing.
What did Globeflex Capital L P sell last quarter?
In Q2 2026, Globeflex Capital L P cut from its top 50 Catalyst Pharmaceuticals Inc (CPRX), cut from its top 50 Marex Group PLC (MRX), cut from its top 50 Credicorp Ltd (BAP), cut from its top 50 Nextpower Inc (NXT), cut from its top 50 Xp Inc (XP), Mks Inc. (MKSI) (-16.3% shares), Medpace Hldgs Inc (MEDP) (-15.1% shares) and Comfort Sys USA Inc (FIX) (-13.1% shares), compared with its Q1 2026 filing.
How has Globeflex Capital L P's portfolio performed?
A portfolio copying Globeflex Capital L P's 20 largest 13F holdings each quarter, from the day each filing was public, returned +17.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +33.5% against +20.1%. Over 5 years: +8.4% a year against +11.6%.
When is Globeflex Capital L P's next 13F filing due?
13F filings are due 45 days after each quarter ends. Globeflex Capital L P's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.